1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]-

Request For Quotation
1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]- Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 18916372613
Email: yanzihan@shyuanye.com
Company Name: Tianjin Kailiqi Biotechnology Co., Ltd.  
Tel: 15076683720
Email: klq@cw-bio.com
Company Name: Jinan Jiuli Biotechnology Co. , Ltd.  
Tel: 15865264761
Email: 486064515@qq.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-1647117 13681763483
Email: product02@bidepharm.com

1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]- manufacturers
1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]- Basic information
Product Name:1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]-
Synonyms:1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]-;WAY-637471;2-(4-Fluorophenyl)-5-(((5-(furan-2-yl)-1,3,4-oxadiazol-2-yl)thio)methyl)-1,3,4-oxadiazole;Tuberculosis inhibitor 12
CAS:793729-44-9
MF:C15H9FN4O3S
MW:344.32
EINECS:
Product Categories:
Mol File:793729-44-9.mol
1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]- Structure
1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]- Chemical Properties
Boiling point 521.2±60.0 °C(Predicted)
density 1.54±0.1 g/cm3(Predicted)
form Solid
pka-5.78±0.37(Predicted)
color Yellow to brown
Safety Information
MSDS Information
1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]- Usage And Synthesis
UsesTuberculosis inhibitor 12 (compound 12) is an oxadiazole derivative and an inhibitor of Mycobacterium tuberculosis. The inhibition rates of Tuberculosis inhibitor 12 (20 μM) on 7H9-Tw-OADC and 7H9-Tw-OADC reached 82% and 78% respectively[1].
References[1] Early JV, et al. Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2016 May 23;60(6):3608-16. DOI:10.1128/AAC.02896-15
1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]- Preparation Products And Raw materials
Tag:1,3,4-Oxadiazole, 2-(4-fluorophenyl)-5-[[[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]thio]methyl]-(793729-44-9) Related Product Information
Rapamycin Carbonyl cyanide 3-chlorophenylhydrazone Brefeldin A Neomycin sulfate Streptozotocin Methotrexate